ANG Lifesciences

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE236W01016
  • NSEID:
  • BSEID: 540694
INR
36.34
-0.74 (-2.0%)
BSENSE

Oct 09

BSE+NSE Vol: 2.21 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
Share Capital
17.75
17.75
17.75
17.75
15.06
Share Warrants & Outstandings
Total Reserve
35.14
46.23
58.53
68.47
68.71
Shareholder's Funds
52.89
63.98
76.28
86.22
83.77
Minority Interest
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
4.62
18.86
13.95
18.49
21.64
Secured Loans
4.48
8.49
12.91
17.35
20.79
Unsecured Loans
0.13
10.38
1.04
1.14
0.84
Deferred Tax Assets / Liabilities
-8.27
-6.37
-3.13
-2.63
-3.67
Other Long Term Liabilities
1.09
2.04
2.95
6.14
15.48
Long Term Trade Payables
0.00
0.00
2.22
1.97
1.75
Long Term Provisions
1.31
1.28
1.14
1.06
1.49
Total Non-Current Liabilities
-1.25
15.81
17.13
25.04
36.69
Current Liabilities
Trade Payables
52.51
66.07
66.18
68.19
70.63
Other Current Liabilities
23.35
15.59
22.97
44.56
40.12
Short Term Borrowings
72.91
61.57
55.30
49.44
55.36
Short Term Provisions
0.26
0.20
0.12
0.09
0.18
Total Current Liabilities
149.04
143.44
144.57
162.28
166.29
Total Liabilities
200.68
223.22
237.98
273.54
286.75
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
Gross Block
120.38
121.61
116.05
143.87
141.97
Less: Accumulated Depreciation
71.35
66.88
61.00
58.45
49.36
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
Net Block
49.03
54.73
55.06
85.42
92.61
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.03
0.03
0.03
0.03
0.03
Long Term Loans & Advances
0.68
0.66
0.62
0.52
0.41
Other Non Current Assets
0.00
0.00
5.62
1.70
0.88
Total Non-Current Assets
51.32
57.88
64.67
90.39
93.93
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
Inventories
46.26
54.11
47.77
48.49
36.96
Sundry Debtors
67.93
66.54
73.28
83.15
102.06
Cash and Bank
3.79
3.64
5.74
6.18
6.65
Other Current Assets
5.52
5.45
1.02
1.86
1.40
Short Term Loans and Advances
25.85
35.61
45.52
43.48
45.75
Total Current Assets
149.35
165.34
173.31
183.15
192.81
Net Current Assets (Including Current Investments)
0.32
21.90
28.75
20.87
26.52
Total Current Assets Excluding Current Investments
149.35
165.34
173.31
183.15
192.81
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
Total Assets
200.68
223.22
237.98
273.54
286.75
Contingent Liabilities
2.21
14.15
15.66
16.63
20.30
Total Debt
77.53
80.43
69.25
67.94
77.00
Book Value per share (adjusted)
0
45.4
54.82
62.43
61.024
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is -3.61% vs 16.14% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is -46.57% vs -30.85% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is -10.41% vs -0.60% in Mar 2025

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is -9.67% vs -4.60% in Mar 2025

Compare Balance Sheet Results of ANG Lifesciences
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
17.75
0
17.75
0.00%
Share Warrants & Outstandings
Total Reserve
35.14
0
35.14
0.00%
Shareholder's Funds
52.89
0
52.89
0.00%
Minority Interest
0.00
0
0.00
0.00%
Long-Term Borrowings
4.62
0
4.62
0.00%
Secured Loans
4.48
0
4.48
0.00%
Unsecured Loans
0.13
0
0.13
0.00%
Deferred Tax Assets / Liabilities
-8.27
0
-8.27
0.00%
Other Long Term Liabilities
1.09
0
1.09
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
1.31
0
1.31
0.00%
Total Non-Current Liabilities
-1.25
0
-1.25
0.00%
Current Liabilities
Trade Payables
52.51
0
52.51
0.00%
Other Current Liabilities
23.35
0
23.35
0.00%
Short Term Borrowings
72.91
0
72.91
0.00%
Short Term Provisions
0.26
0
0.26
0.00%
Total Current Liabilities
149.04
0
149.04
0.00%
Total Liabilities
200.68
0
200.68
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
120.38
0
120.38
0.00%
Less: Accumulated Depreciation
71.35
0
71.35
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
49.03
0
49.03
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
0.00
0
0.00
0.00%
Intangible assets under development
0.00
0
0.00
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
0.03
0
0.03
0.00%
Long Term Loans & Advances
0.68
0
0.68
0.00%
Other Non Current Assets
0.00
0
0.00
0.00%
Total Non-Current Assets
51.32
0
51.32
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
46.26
0
46.26
0.00%
Sundry Debtors
67.93
0
67.93
0.00%
Cash and Bank
3.79
0
3.79
0.00%
Other Current Assets
5.52
0
5.52
0.00%
Short Term Loans and Advances
25.85
0
25.85
0.00%
Total Current Assets
149.35
0
149.35
0.00%
Net Current Assets (Including Current Investments)
0.32
0
0.32
0.00%
Total Current Assets Excluding Current Investments
149.35
0
149.35
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
200.68
0
200.68
0.00%
Contingent Liabilities
2.21
0
2.21
0.00%
Total Debt
77.53
0
77.53
0.00%
Book Value per share (adjusted)
0.00
0
0.00
0.00%
Annual - Borrowings
Borrowings 77.53 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -3.61% vs 16.14% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.09 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -46.57% vs -30.85% in Mar 2025

Annual - Fixed Assets
Fixed Assets 49.03 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -10.41% vs -0.60% in Mar 2025

Annual - Investments
Investments 0.03 Cr
in Mar 2026

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 149.35 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -9.67% vs -4.60% in Mar 2025

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."